Delivery Order SPE2DB24D2010-SPE2DB24FZTZ1
Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products to the Defense Logistics Agency (DLA). The $3,144.83 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $11,588.58, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a firm fixed-price pricing type and a completion date of June 13, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery...
- The federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $6,031.75 and is a firm fixed-price delivery order that runs through January 30, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $10,861.95, was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 28, 2023. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products to the Defense Logistics Agency (DLA). The $30,420.65 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on July 29, 2024, with a completion date of July 30, 2024. The contract does not have a set-aside designation. As a significant supplier of medical commodities to federal agencies, AmerisourceBergen holds...
- This federal contract award, valued at $7,229.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "MONOVISC 88 MG/4 ML SYRINGE 4ML" and has a firm fixed price pricing type. The contract is not set aside and has an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The award, valued at $14,338.67, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is May 10, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,641.09 firm-fixed-price award was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 21, 2024, with a completion date of February 22, 2024. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value...
- This federal contract award is for the delivery of Monovisc 88 mg/4 ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,287.32, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price, and the ultimate completion date is January 31, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,906.08 firm fixed-price delivery order is for MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...